Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Neuroprotective Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroprotective Agents (pharmacology) < Neuroprotective Agents (therapeutic use) < Neuroprotective Agents (toxicity)  Facettes :

List of bibliographic references indexed by Neuroprotective Agents (therapeutic use)

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000404 (2014) Andrew B. WestTen Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors to the Clinic
000453 (2014) Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart IsaacsonRandomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease.
000459 (2014) Abhishek Chandra ; Ashu Johri ; M. Flint BealProspects for Neuroprotective Therapies in Prodromal Huntington's disease
000714 (2013) Anthony E. Lang [Canada] ; Eldad Melamed ; Werner Poewe [Autriche] ; Olivier RascolTrial designs used to study neuroprotective therapy in Parkinson's disease.
000725 (2013) C Warren Olanow [États-Unis] ; Jose A. Obeso ; Fabrizio StocchiThe vatican meeting on neuroprotection for Parkinson's disease.
000789 (2013) Katherine L. Possin ; Gail A. Kang ; Christine Guo ; Eric M. Fine ; Andrew J. Trujillo ; Caroline A. Racine ; Reva Wilheim ; Erica T. Johnson ; Jennifer L. Witt ; William W. Seeley ; Bruce L. Miller ; Joel H. KramerRivastigmine is Associated with Restoration of Left Frontal Brain Activity in Parkinson’s Disease
000862 (2013) C Warren Olanow [États-Unis] ; Patrik BrundinParkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
000873 (2013) Fabrizio Stocchi [Italie] ; C Warren OlanowObstacles to the development of a neuroprotective therapy for Parkinson's disease.
000922 (2013) Radu Constantinescu [États-Unis] ; Jordan Elm [États-Unis] ; Peggy Auinger [États-Unis] ; Saloni Sharma [États-Unis] ; Erika F. Augustine [États-Unis] ; Laith Khadim [États-Unis] ; Karl Kieburtz [États-Unis]Malignant Melanoma in Early-Treated Parkinson's Disease: The NET-PD Trial
000A01 (2013) Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000A07 (2013) Antje Haehner ; Thomas Hummel ; Martin Wolz ; Lisa Klingelhöfer ; Mareike Fauser ; Alexander Storch ; Heinz ReichmannEffects of rasagiline on olfactory function in patients with Parkinson’s disease.
000A86 (2013) Pankaj A. Agarwal [Canada] ; A Jon StoesslBiomarkers for trials of neuroprotection in Parkinson's disease.
000C54 (2012) Johannes R. Streffer [Belgique] ; Igor D. Grachev ; Cheryl Fitzer-Attas ; Baltazar Gomez-Mancilla ; Babak Boroojerdi ; Juliana Bronzova ; Susanne Ostrowitzki ; Stephen J. Victor ; Paulo Fontoura ; Robert AlexanderPrerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.
000C63 (2012) Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl KieburtzPharmacologic approaches to the treatment of Huntington's disease.
000C94 (2012) Paolo Calabresi [Italie] ; Massimiliano Di Filippo [Italie] ; Antongiulio Gallina [Italie] ; Yingfei Wang [États-Unis] ; Jeannette N. Stankowski [États-Unis] ; Barbara Picconi [Italie] ; Valina L. Dawson [États-Unis] ; Ted M. Dawson [États-Unis]New Synaptic and Molecular Targets for Neuroprotection in Parkinson’s Disease
000E87 (2012) Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni]Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies
001331 (2011) Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
001363 (2011) Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada]Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease
001667 (2011) Peter Jenner [Royaume-Uni] ; J. William Langston [États-Unis]Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
001710 (2011) Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis]Determination of minimal clinically important change in early and advanced Parkinson's disease
001B81 (2010) Richard Dodel [Allemagne] ; Annika Spottke [Allemagne] ; Alexander Gerhard [Royaume-Uni] ; Alexander Reuss [Allemagne] ; Sylvia Reinecker [Allemagne] ; Nicole Schimke [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Friederike Sixel-Döring [Allemagne] ; Birgit Herting [Allemagne] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Martin Sawires [Autriche] ; Felix Geser [Autriche] ; Martin Köllensperger [Autriche] ; Klaus Seppi [Autriche] ; Manja Kloss [Allemagne] ; Martin Krause [Allemagne] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Silke Böttger [Allemagne] ; Markus Naumann [Allemagne] ; Axel Lipp [Royaume-Uni] ; Doreen Gruber [Allemagne] ; Andreas Kupsch [Allemagne] ; Yansheng Du [États-Unis] ; Federico Turkheimer [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Carmen Schade-Brittinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Karla Eggert [Allemagne]Minocycline 1‐year therapy in multiple‐system‐atrophy: Effect on clinical symptoms and [11C] (R)‐PK11195 PET (MEMSA‐trial)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Neuroprotective Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Neuroprotective Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neuroprotective Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024